This market is driven by several market forces that shape its dynamics and growth path. One important factor is the growing demand for sophisticated medical technologies, particularly in healthcare. The continuous need for efficient and fast thawing of biological samples and products in the health care sector has led to the expansion of this market. Consequently, thawing systems are increasingly being adopted as medical researches/ applications grow more complex necessitating precise and swift thawing procedures.
Furthermore, global rise in chronic diseases together with increasing focus on personalized medicine are playing a leading role towards its evolution. Thawing system plays an essential role in conserving the integrity of biological materials including blood components or stem cells which are used in modern medical treatments. Increasing prevalence of chronic diseases alongside growing scope of personalized medication are driving demand for thawing systems across various healthcare facilities.
Another key market factor is the growing emphasis on food safety as well as surging demand for quick and convenient solutions in the food industry. They find extensive use when it comes to unfreezing frozen food products thereby ensuring rapid and controlled manner of achieving this objective. In order to improve their processes of production, food manufacturers have started adopting thawing systems because consumers have become increasingly critical about quality and safety issues related to food stuffs.Why then does all this mean?
Moreover, advancements and innovations taking place in this area dictate the market landscape today . Manufactures continue investing lots resources on research with an aim to come up with cutting-edge thawing technologies that offer enhanced efficiency, accuracy aiming at enhancing user-friendliness as well. At present, smart technology integration together with automation has taken roots into these defrost devices which cascades greater controls-monitoring by end users themselves.Consequently, there is expanding product base but also they are getting popular among various industries through such innovative processes.
Similarly, strict regulations & standards regarding handling or thawing biological materials affect how it operates.Thermo-Regulatory measures are very stringent in the healthcare, biotechnology & pharmaceutical sectors. These types of thawing systems which meet such standards that are set by authorities can experience an increase in demand as they help to maintain product integrity and quality. Therefore, manufacturers within the thawing system markets align their product development strategies with regulatory requirements in order to comply with strict standards.
Additionally, some regional factors such as economic development; healthcare infrastructure and overall industrial condition also affect the market. Emerging economies having a growing healthcare sector coupled with increasing investments into r&d represent lucrative thawing systems’ markets. In addition, expansion of these regions’ biopharmaceutical industries has resulted to the growth of this market since defrosting systems form a critical part of the production and development processes for biopharmaceutical products.”
Report Attribute/Metric | Details |
---|---|
Growth Rate | 10.8% (2022-2030) |
The Thawing System Market Size was valued at USD 0.10 Billion in 2023. The Global Thawing System industry is projected to grow from USD 0.20 Billion in 2024 to USD 0.40 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 12.80% during the forecast period (2024 - 2032). Thawing system is used for safe storage and transport of biopharmaceuticals products. There are two major types thawing system used manual and automated.
In June 2023, Helmer Scientific launched a new thawing system for use in the food and beverage industry. The system is said to be capable of quickly and safely thawing frozen food products without compromising their quality.
In May 2023, Sarstedt unveiled a novel defrosting device that targets medical applications. The machine has been touted as being capable of rapidly thawing out frozen blood products along with other medical supplies safely while not affecting their efficacy.
In April 2023, Sartorius launched a new thawing system for use in the industrial sector. It is said that this system can quickly and safely thaw industrial pipes and other industrial equipments without destroying them.
Biocision has released a novel defrosting device meant for research and development industry during March 2023. As per findings, this particular instrument can immediately defrost cell samples within minutes without damage.
Boekel Scientific introduced a new thawing unit for use in the laboratory industry back in February 2023. Its manufacturers have claimed that without any loss or damage, it unfreezes all forms of frozen samples more securely.
For instance, an update on BioLife Solutions’ intellectual property expansion was issued by BioLife Solutions Inc., a producer and developer of revolutionary bioproduction goods/services meant specifically for cell/gene therapy (CGT) together with the bigger biopharma markets in November 2022. In relation to its platform technologies for cell processing, media, storage containers, freezers and thaw systems it received seven patents from USPTO or other patent offices outside U.S., filed 43 new patent applications covering novel inventions including different aspects of our proprietary Stirling engine technology.
In December 2021, Sartorius entered into partnership with HOF Sonderanlagenbau whereby two HOF horizontal plate freeze-thaw units would be integrated into Sartorius’s portfolio so that customers could access full range compatible freeze-thaw equipment and consumables. This step made it possible for faster and easier implementation of robust frozen drug substance management platforms through improvement of validation and purchase support from a single supplier.
The factors such as increasing technological advancements in thawing devices is the major driving factor for the market. Beside this rising use of thawed cells in the research and treatment of diabetes and cancer has provided fuel for the growth of the market. High cost of the automation may restrain the growth of the market.
According to Centers for Disease Control and Prevention, in 2017, more than 30.3 Million Americans which is nearly 1 in 10 have diabetes. According to WHO, the number of people with diabetes has risen from 108 Million in 1980 to 422 Million in 2014. Moreover, Diabetes prevalence has been increasing in low-middle income countries.
The Thawing System Market has been segmented into type, sample type, and end user.
By type, the market has been segmented into manual devices and automated devices.
Based on sample type, the market has been segmented into blood, plasma, stem cells, whole blood & red blood cells, platelets, embryos, ovum, semen, and others.
The Thawing System Market, by end user, has been segmented into blood banks & transfusion centers, hospitals & diagnostic laboratories, research & academic institutes, biotechnology & pharmaceutical companies, and others.
The Thawing System Market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Thawing System Market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada. The European Thawing System Market has been segmented into Western Europe and Eastern Europe. The Western Europe tThawing System Market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The Thawing System Market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The thawing system market in the Middle East & Africa has been segmented into the Middle East and Africa.
Key Companies in the thawing system market include
Some of the prominent players in the thawing system market are
Geographically, the Americas is anticipated to dominate the thawing system market owing to the high domestic income, and presence of major market players. According to the US Investments in Medical and Health Research and Development 2013-2015, a report by Research America, in 2015, total US medical and health R&D in the US was USD 158.7 billion.
Europe is expected to hold the second largest position in the thawing system market. The market growth in this region is attributed to the presence of strong academic & research base and availability of funding for research in the European countries. For instance, the European Research Council (ERC) provides grants for technological and scientific research conducted within the European Union (EU).
The Thawing System Market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region owing to increasing government focus on biomedical and biotechnology sector and growing number of target population in the region.
The Middle East & Africa has the lowest share of the global thawing system market. Majority of the market of the region is anticipated to be held by the Middle East region owing to the growing government initiatives for the healthcare sector.
Intended Audience:
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)